Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3

Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3 is an acid terminated Pharma / Medical Grade homopolymer of DL-lactide with an inherent viscosity midpoint of 1.4 dl/g. It is supplied in the form of white micronized powder.

Get Quote

Description

CAS Number26023-30-3
Systematic NamePoly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Injectable Poly-Dl-lactic Acid, Ultra-Pure PDLLA.
EPA Registry NamePolylactic acid
Substance TypePLA | DL10014A | Inherent Viscosity : 1.3 - 1.7 dL/g | Acid terminated |DL- Lactide 100% | Mw 130-220 kDa Biodegradable Polymer, Excipient, Non-Active pharmaceutical ingredient, Nanoparticles.
SynonymPLA, Poly(DL-lactide) acid terminated, PDLLA
ApplicationsDrug delivery formulations, ACL Scrow, bioresorbable implants.

Additional information

Appearance

White powder.

Solubility

Soluble in methylene chloride. Insoluble in water.

FT NMR (PROTON)

Should comply

Viscosity (0.5% in CHCl3 at 30°C)

Between 1.30-1.70 dL/g

Residual monomer L-Lactide

≤ 0.5 %

Residual solvent acetone

≤ 0.1 %

Residual solvent toluene

≤ 890 PPM

Total Residual solvent

≤ 1000 PPM

Acid number

8 – 15 mg KOH/g

Heavy metal

≤ 10 PPM

Tin

≤ 200 PPM

Sulphated Ash

≤ 0.1 %

TAMC

≤ 2000 CFU/g

TYMC

≤ 200 CFU/g

Bacterial Endotoxins

≤ 2000 EU/g

Self life

2 Years

Get Quote for Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3